InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,713.64
(
1.70%
)
US TECH 100
19,304.80
(
2.37%
)
Dow Jones
42,025.19
(
1.26%
)
Brent Oil
74.04
(
-0.38%
)
Bitcoin
63,850.16
(
1.44%
)
Post# of 13962
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Bigtrade PT

Send PM Follow Ignore
Followers 47
Posts 3764
Boards Moderated 0
Alias Born 04/05/2011

Bigtrade PT

Re: None

Wednesday, 03/07/2018 4:53:35 PM

Wednesday, March 07, 2018 4:53:35 PM

Post# of 13962
Immune Pharmaceuticals Inc. (NASDAQ:IMNP) shares have been labeled a top pick by Beta Research as it meets the A+ criteria outlined by the firm. The stock boasts a consensus analyst “Buy” rating with the consensus recommendation standing at 2.00. This is according to all covering research brokerage firms taken into consideration by First Call. The consensus price target of $3.00 also implies significant upside from the current price of $0.39.

https://yankeeanalysts.com/stock-review-consensus-look-at-immune-pharmaceuticals-inc-nasdaqimnp-rxi-pharmaceuticals-corporation-nasdaqrxii/35658/

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up